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Available online 14 November 2006β-N-oxalyl-amino-L-alanine, (L-BOAA), an excitatory amino acid, acts as an agonist of the
AMPA subtype of glutamate receptors. It inhibits mitochondrial complex I in motor cortex
and lumbosacral cord of male mice through oxidation of critical thiol groups, and
glutaredoxin, a thiol disulfide oxido-reductase, helps maintain integrity of complex I.
Since incidence of neurolathyrism is less common inwomen,we examined themechanisms
underlying the gender-related effects. Inhibition of complex I activity by L-BOAAwas seen in
male but not femalemice. Pretreatment of femalemicewith estrogen receptor antagonist ICI
182,780 or tamoxifen sensitizes them to L-BOAA toxicity, indicating that the neuroprotection
is mediated by estrogen receptors. L-BOAA triggers glutathione (GSH) loss in male mice but
not in female mice, and only a small but significant increase in oxidized glutathione (GSSG)
was seen in females. As a consequence, up-regulation of γ-glutamyl cysteinyl synthase (the
rate-limiting enzyme in glutathione synthesis) was seen only in male mouse CNS but not in
females. Both glutathione reductase and glutaredoxin that reduce oxidized glutathione and
protein glutathione mixed disulfides, respectively, were constitutively expressed at higher
levels in females. Furthermore, glutaredoxin activity in female mice was down-regulated by
estrogen antagonist indicating its regulation by estrogen receptor. The higher constitutive
expression of glutathione reductase and glutaredoxin could potentially confer
neuroprotection to female mice.
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disulfides1. Introduction
Neurolathyrism is a typeofmotorneurondisease involving the
upper motor neurons, degeneration of anterior horn cells and
loss of axons in the pyramidal tracts in the lumbar spinal cord
in humans (Roy, 1988). Neurolathyrism is caused by consump-rch Centre, Nainwal Mod
ranath).
er B.V. All rights reservedtion of the drought resistant chickling pea from plant Lathyrus
sativus that contains the glutamate agonist β-N-oxalyl-amino-
L-alanine (L-BOAA, also known as β-N-oxalyl-α-β-diamino
propionic acid, β-ODAP). L-BOAA mediates neurotoxicity
through the AMPA subtype of glutamate receptor (Sriram
et al., 1997).e, Manesar, 122050, India. Fax: +91 124 2338928.
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protein–glutathione mixed disulfides (PrSSG) that results in
inhibition of mitochondrial complex I, a major component of
the mitochondrial electron transport chain, in motor cortex
(MC) and lumbosacral cord (LSC) of male mice. The inhibition
of mitochondrial complex I activity by L-BOAA presumably
occurs through glutathionylation of critical thiol groups in
subunits of complex I since it can be reversed in vitro by thiol
reductants (Kenchappa et al., 2002; Taylor et al., 2003).
Glutaredoxin (also known as thioltransferase; Grx1; EC
1.8.4.2), a thiol-disulfide oxido-reductase, specifically and
efficiently reduces glutathionylated proteins to protein thiols
(Chrestensen et al., 2000; Gravina and Mieyal, 1993). It is
essential for maintenance of complex I function in normal
conditions (Kenchappa and Ravindranath, 2003b) and its up-
regulation is critical for recovery of complex I function
following L-BOAA administration (Kenchappa et al., 2002).
In humans, the incidence of neurolathyrism is more
common in men (1.5 times more), while women are less
prone to the disease although consumption of the chickling
pea is not significantly different (Roy, 1988). This gender
difference in the neurotoxic response to L-BOAA is reflected in
the mouse model of L-BOAA toxicity (Sriram et al., 1998). The
animal model of L-BOAA toxicity not only mimics the gender
difference but also the site specificity of L-BOAA action
wherein only motor cortex and lumbosacral cord are affected
(Sriram et al., 1998). We, therefore, examined the molecular
mechanisms underlying the neuroprotection against excito-
toxicity seen in female mice using this model.Fig. 1 – Effect of L-BOAA on complex I activity in male and fema
administered a single dose of L-BOAA (10 mg/kg body weight, s.c
animals received vehicle alone (black bars). Complex I activity wa
femalemice. The activity is expressed as nanomoles of NADH oxi
Asterisks indicate values significantly different from vehicle trea
lumbosacral cord of male mice treated with L-BOAA (10 mg/kg bo
with (+DTT) and without (−DTT) for 30 min at 37 °C, and comple2. Results
2.1. Complex I activity is unaltered in female mouse brain
after L-BOAA administration
Male and female mice were administrated a single dose of
L-BOAA (10 mg/kg body weight, s.c.). Complex I activity was
significantly decreased in motor cortex and lumbosacral cord
of male mice at 0.5 h after L-BOAA administration (39% lower
than controls, Fig. 1a). In femalemice, there was no significant
change in complex I activity in motor cortex and lumbosacral
cord as compared to respective controls after L-BOAA adminis-
tration (Fig. 1a). Mitochondria obtained from lumbosacral cord
of male mice treated with L-BOAAwere incubated with DTT at
37 °C. DTT treatment reversed complex I inhibition caused by
L-BOAA in lumbosacral cord, indicating that the inhibition is
caused by oxidation of critical thiols of complex I subunits
(Fig. 1b).
2.2. Estrogen receptor antagonist renders female mice
vulnerable to L-BOAA mediated complex I inhibition
When sagittal slices of male mouse brain were preincu-
bated with 17β-estradiol (100 μM) for 0.5 h prior to exposure
to L-BOAA, they were protected from L-BOAA mediated
complex I loss (Fig. 2a). Female mouse brain slices pretreated
with tamoxifen (an estrogen receptor modulator; Shiau et al.,
1998) were vulnerable to L-BOAA (Fig. 2b). Pretreatment withle mouse brain regions. (a) Male and female mice were
.), and animals were killed 0.5 h later (gray bars). Control
s estimated inmotor cortex and lumbosacral cord ofmale and
dised/min/mg protein. Values aremean±SEM (n=4 animals).
ted controls (P<0.001). (b) Mitochondria were isolated from
dy weight s.c.) for 1 h. Mitochondrial samples were incubated
x I activity was measured.
Fig. 2 – Effect of 17β-estradiol, tamoxifen and ICI 182,780 pretreatment on L-BOAA toxicity in male and female mouse brain
slices. Sagittal slices prepared from male mouse brain were preincubated with estrogen (100 μM) in ACSF for 0.5 h
followed by incubation with L-BOAA (1 nM) for 1 h. Complex I activity was measured in mitochondrial preparation from
brain slices. Values are mean±SEM (n=5 slices). Asterisks indicate values significantly different from respective
controls (P<0.001). Sagittal slices prepared from female mouse brain were preincubated with tamoxifen (10 nM) in ACSF
for 0.5 h followed by incubation with L-BOAA (1 nM) for 1 h. Sagittal slices from male and female mouse were
preincubated with ICI 182,780 (1 nM) for 0.5 h followed by incubation with L-BOAA (1 nM) for 1 h. Complex I activity was
measured in mitochondrial preparation from above brain slices. Values are mean±SEM (n=5 slices). Complex I activity
was expressed as nanomoles of NADH oxidized/min/mg protein. Asterisks indicate values significantly different from
respective controls (P<0.001).
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incubation with L-BOAA (1 nM) for 1 h, abolished the
neuroprotection seen in females and resulted in significant
inhibition of complex I activity (Figs. 2c and d) in female,
similar to that seen in males.
2.3. GSH levels and γ-GCS expression are unaltered in
female mouse brain after L-BOAA administration
Total GSH content was measured 1 h after L-BOAA adminis-
tration in motor cortex and lumbosacral cord regions of the
CNS affected by L-BOAA. There was a significant decrease in
GSH levels in the motor cortex and lumbosacral cord of the
male mice (31% and 35% lower than controls, respectively,
Fig. 3a). We estimated the levels of mRNA and activity of
γ-glutamyl cysteine synthetase (the rate-limiting enzyme in
GSH biosynthesis, γ-GCS) in male and female CNS regions
after L-BOAA treatment. One hour after a single dose of L-
BOAA, a significant increase in the levels of both mRNA and
activity of γ-GCS was noted in motor cortex and lumbosacralcord of male mice, while they were similar to controls in
females (Figs. 3b–d).
2.4. Higher expression of glutathione reductase and
glutaredoxin protects female mice against L-BOAA toxicity
GSSG levels in the motor cortex of female mice increased 1 h
after L-BOAA treatment (240% higher than corresponding
control, Fig. 4a) indicating the generation of oxidative stress
but this did not further translate into loss of GSH. Glutathione
reductase (the key enzyme involved in reduction of GSSG to
GSH) activity was higher in female mouse brain compared to
male (Fig. 4b).Whenwe examined glutaredoxin activity in CNS
regions from femalemice and compared it withmalemice, we
found that the activity in lumbosacral cord and motor cortex
of female mice was significantly higher (197% and 196%
respectively, Fig. 4c). In order to determine if glutaredoxin
expression was regulated by estrogen through estrogen
receptor(s) mediated signaling, we treated animals with ICI
182,780 (antagonist of both α and β estrogen receptor) and
Fig. 3 – Change in (a) GSH levels, (b) γ-GCS activity and (c) mRNA levels of γ-GCS heavy chain subunit in male and female mice
following L-BOAA exposure. Male and female mice were administered a single dose of L-BOAA (10 mg/kg bodyweight, s.c.),
and animals were killed 1 h later (black bars). Control animals received vehicle alone (white bars). (a) GSH level was estimated
in motor cortex (MC) and lumbosacral cord (LSC) of male and female mice. Values are mean±SEM (n=4 animals) (b). γ-GCS
activity was measured in motor cortex (MC) and lumbosacral cord (LSC) of male and female mice from control (black bars) and
L-BOAA treated animals (gray bars). Values are mean±SEM (n=4 animals). Asterisks indicate values significantly different
from vehicle treated controls (P<0.001) (b). (c) A representative northern blot and corresponding 18S rRNA band of the total RNA
from motor cortex (MC; lanes 1 and 2 for males, 5 and 6 for females) from controls (lanes 1 and 5) and L-BOAA treated (lanes 2
and 6) animals, respectively. Northern blot of RNA from lumbosacral cord (LSC; lanes 3 and 4 for males; 7 and 8 for females)
from controls (lanes 3 and 7) and L-BOAA treated (lanes 4 and 8) animals is also depicted. (d) Densitometric analyses of
northern blot representing relative intensity of the hybridized bands from controls (black bars) and L-BOAA treated animals
(gray bars). Values are mean±SEM (n=3 individual experiments). Asterisks indicate values significantly different from controls
(P<0.001).
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of estrogen receptor(s) led to significant decrease in glutar-
edoxin activity (26% and 16% respectively) in lumbosacral cord
and motor cortex (Fig. 4d).
2.5. Immunohistochemical localization of estrogen receptor
α and β in mouse brain
Immunohistochemical studies demonstrated the presence of
both α and β estrogen receptors in the cortex and lumbar
spinal cord of mouse brain (Fig. 5) indicating that estrogenreceptor mediated signaling could potentially occur at these
sites.3. Discussion
Estrogen, a neuroprotective agent (Behl, 2002; Dubal et al.,
1998; Green and Simpkins, 2000; Hurn and Macrae, 2000), acts
by two pathways at pharmacological (non-classical) and
physiological (classical) concentrations. At pharmacological
concentration, estrogen has high intrinsic antioxidant activity
Fig. 4 – Effect of L-BOAA on GSSG levels and glutathione reductase and glutaredoxin activities: (a) Male and female mice were
administered a single dose of L-BOAA (10 mg/kg bodyweight, s.c.), and animals were killed 1 h later. Control animals received
vehicle alone. GSSG levels were estimated inmotor cortex of femalemice and are expressed as nanomoles of GSSG/mg protein.
(b) Glutathione reductase activity wasmeasured inmale and female mouse brain and expressed as nanomoles of NADPH/min/
mg protein. (c) Glutaredoxin activity was measured in motor cortex (MC) and lumbosacral cord (LSC) of male (white bars) and
femalemice (black bars) (c). (d) Femalemice were treated with vehicle (white bars) or ICI 182,780 (1mg/kg bodyweight) daily for
15 days (black bars), and glutaredoxin activity wasmeasured. Values aremean±SEM (n=3 animals) expressed as nanomoles of
NADPH utilized/min/mg protein. Asterisks indicate values significantly different from males (as in ‘b’) or controls (as in ‘d’;
P<0.01).
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pharmacological concentration up to 1.0 μM inhibits lipid
peroxidation and protects neurons against oxidative stress
and glutamate-induced excitotoxicity, in vitro (Behl, 2002). In
vivo, the physiological mode of estrogen action is mediated by
estrogen receptors and involves induction or repression of
gene expression leading to long-term genetic and physiologi-
cal response. The precise molecular and cellular mechanisms
underlying the physiological mode of estrogen mediated
neuroprotection remain unclear. In this study, we demon-
strate that estrogen regulates the expression of two key
enzymes involved in maintenance of redox status, namely,
glutaredoxin and glutathione reductase, and thereby helps
maintain the redox status of proteins includingmitochondrial
complex I although there are no significant differences in the
levels of GSH or the rate-limiting enzyme for GSH synthesis, γ-
glutamyl cysteine synthase.
Earlier studies from our laboratory have shown that
female mice are resistant to L-BOAA toxicity (Sriram et al.,
1998). The early, reversible events (Kenchappa et al., 2002) in
motor cortex and lumbosacral cord following L-BOAA admin-
istration involve loss of GSH, up-regulation of the glutare-
doxin and γ-glutamyl cysteinyl synthase mRNA and protein
(Kenchappa et al., 2002; Kenchappa and Ravindranath, 2003a).
None of these responses was observed in female mice (Figs. 1
and 3).During oxidative stress, GSH is oxidized to GSSG (oxidized
glutathione), which can modify thiol groups in proteins to
protein–glutathione mixed disulfides (PrSSG) at available
cysteine residues if not extruded from the cell or reduced by
glutathione reductase (Ravindranath and Reed, 1990). In brain,
extrusion of GSSG during oxidative stress is not observed,
however, extensive oxidative modification of protein thiols is
seen as indicated by dramatic increase in PrSSG levels
(Kenchappa et al., 2002; Shivakumar and Ravindranath, 1992).
In the present study, total GSH levels were unaffected in
female mouse brain regions following L-BOAA treatment,
while there was significant loss of GSH (30% decrease) in
males. Oxidized GSH (GSSG) normally represents about 1% of
total GSH in cells. A small but significant increase in GSSG
level (2.4-fold increase over control representing 2.4% of total
GSH) was seen in female mouse brain indicating that L-BOAA
exposure generated oxidative stress in females, but this did
not translate into loss of GSH as seen inmalemouse brain. The
lack of significant loss of GSH in females indicates that protein
thiol modification, if any, occurring through formation of
PrSSG is not sustained and is reduced back to protein thiol
(PrSH) and GSH, thus maintaining GSH levels.
Glutathionylation of proteins can lead to their inactivation.
Complex I contains several cysteine residues in its active site
(Dupuis et al., 1991), and facile glutathionylation of thiol
groups in the 51 and 75 kDa subunits of complex I by GSSG
Fig. 5 – Immunohistochemical localization of estrogen receptorα and β in femalemouse brain: Estrogen receptorsα and β are
expressed in cortical neurons (scale bar=50 μm) and in the lumbar spinal cord (scale bar=25 μm).
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and increase in superoxide production (Taylor et al., 2003).
Glutaredoxin efficiently and specifically catalyzes the reacti-
vation of proteins oxidatively inactivated by S-glutathionyla-
tion (Chrestensen et al., 2000) and is critical for the
maintenance and recovery of complex I activity under normal
conditions and following oxidative stress (Kenchappa and
Ravindranath, 2003b; Kenchappa et al., 2002). The facile
reduction of PrSSG by glutaredoxin in the CNS of female
mice may help to maintain thiol homeostasis and prevent
mitochondrial dysfunction. This was also substantiated by
higher glutathione reductase activity seen in female mice
compared to male. The higher activity of glutathione reduc-
tase in female mice could potentially recycle the GSSG formed
due to oxidative stress caused by L-BOAA back to GSH.
Glutaredoxin is expressed constitutively in higher levels in
motor cortex and lumbosacral cord of female mice compared
tomales. Such gender difference is not noted in the expression
of γ-GCS, the rate-limiting enzyme in GSH synthesis (Figs. 3a, b
and c) or in the levels of GSH. Furthermore, glutaredoxin
activity is decreased by the estrogen antagonist ICI 182,780,
indicating that glutaredoxin is regulated through estrogen
receptors. In male mice, ICI 182,780 did not have any effect
(Fig. 2) indicating the inherent differences in response to
estrogen receptor antagonist between male and female
animals. Estrogen receptors α and β are localized in cortical
neurons and in spinal cord (Fig. 5). In addition, estrogen
receptors are localized primarily in neurons of anterior
olfactory nucleus, cerebral cortex, red nucleus, locus ceruleus,
hippocampus and motor trigeminal nucleus (Shughrue et al.,
1997). Glutaredoxin is also localized in similar cell population
(Balijepalli et al., 1999; Kenchappa et al., 2002). However, it is tobe determined which of the estrogen receptors α or β is
involved in the regulation of glutaredoxin.
Estrogen is known to regulate the expression of several
neuroprotective genes. These include neurotrophic factors
such as nerve growth factor, brain derived neurotrophic factor
(BDNF), neurotrophin 3, their receptors TrkA–C and p75 and
insulin-like growth factor 1 (Blurton-Jones et al., 1999; Sohrabji
et al., 1995). The promoter region of anti-apoptotic genes Bcl2
and BclXL contains ERE, and estrogen enhances their tran-
scription in vitro (Pike, 1999). A third group of genes regulated
by estrogen in neurons is structural proteins such as
neurofilament proteins, microtubulin-associated proteins,
TAU and GAP43 (Brueggemeier et al., 2001; Ferreira and
Caceres, 1991; Scoville et al., 1997; Shughrue and Dorsa, 1993;
Reyna-Neyra et al., 2002). In addition to the above, glutar-
edoxin, the thiol-disulfide oxido-reductase, and glutathione
reductase (Fig. 6)may represent a fourth class of genes that are
regulated by estrogen and are involved in neuroprotection
particularly those related to mitochondrial function.4. Experimental procedures
L-BOAA was obtained from Research Biochemicals Inc., USA.
Cysteinyl-glutathione disulfide was purchased from Toronto
Research Chemicals (Toronto, Canada). TRI reagent was
purchased from Molecular Research Inc (Cincinnati, OH,
USA). A 390 bp fragment of the cDNA to γ-glutamyl cysteine
synthetase (Genbank accession numberJ05181) representing
82–471 bp was a gift from Dr. T. Kavanagh (University of
Washington, USA). Ubiquinone 1 was obtained as a gift from
Eisai Pharmaceutical Company (Tokyo, Japan). ICI 182,780 was
Fig. 6 – Glutathione and protein thiol homeostasis following L-BOAA treatment. L-BOAA triggers loss of glutathione (GSH) in
male mice due to production of reactive oxygen species (ROS) that results in glutathionylation of proteins leading to formation
of protein–glutathione mixed disulfides (PrSSG). This results in inhibition of enzymes, which have thiol groups in their active
site, such as complex I. In female mice, L-BOAA administration does not lead to loss of GSH but only a small increase in GSSG
(oxidized glutathione). Higher constitutive expression of glutaredoxin (Grx1) and glutathione reductase (GRed) may help to
protect female mice from excitotoxins, such as L-BOAA by reducing PrSSG to PrSH (protein thiols) and GSSG to GSH,
respectively, thereby preventing protein modification through glutathionylation.
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blot analysis was performed using digoxigenin-labeling kit
from Roche Biochemicals (Mannheim, Germany). Reductacryl
reagent (dithiothreitol immobilized on polyacrylamide resin)
was purchased from Calbiochem, Dramstadlt, Germany.
Antibodies for estrogen receptors α and β were obtained
from Santa Cruz Biotechnology Inc, California, USA. All other
chemicals and reagents were of analytical grade and were
obtained from Sigma Chemical Company (St. Louis, MO, USA)
or Qualigens (Mumbai, India).
4.1. Animals
Male and female Swiss albino mice (3–4 months old, 25–30 g)
were obtained from the Central Animal Research Facility of
the National Institute of Mental Health and Neurosciences.
Animals had free access to pelleted diet (Lipton Calcutta,
India) and water ad libitum. All animal experiments were
carried out according to National Institutes of Health Guide-
lines for the Care and Use of Laboratory Animals. All efforts were
made to minimize animal suffering, to reduce number of
animals used and to employ alternatives to in vivo techniques,
if available.
In vitro studies were performed using sagittal slices
(representing most brain regions) of female mouse brain of 1
mm thickness, as described earlier (Pai et al., 1991). The slices
were incubated at 37 °C in artificial cerebrospinal fluid (ACSF),
pH 7.4, containing sodium chloride (122 mM), potassium
chloride (3.1 mM), calcium chloride (1.3 mM), magnesium
sulfate (1.2 mM), glucose (10mM) and glycyl glycine (30mM) in
an oxygen rich atmosphere with or without L-BOAA (1 nM) for
1 h. In some experiments slices were pretreated with ICI
182,780 (1 nM) for 0.5 h prior to incubation with L-BOAA (1 nM)for 1 h. Following incubation, the slices were removed and
homogenized as such in 0.25 M sucrose, and centrifuged at
1000×g for 10 min. The post-nuclear supernatant was recen-
trifuged at 14,000×g for 30 min to obtain mitochondrial pellet.
Mitochondrial pellet was suspended in sucrose (0.25 M) and
freeze–thawed prior to measurement of complex I activity.
For in vivo studies, L-BOAA (10mg/kg body weight, s.c.) was
dissolved in normal saline and animals were killed at 0.5 or 1 h
after L-BOAA treatment. Motor cortex and lumbosacral
segment of the spinal cord were dissected out and processed
for experimental procedures.
4.2. Processing of tissue
CNS regions were dissected out and immediately processed
for measurement of activities of complex I, glutaredoxin and
γ-glutamyl cysteine synthetase (γ-GCS) and estimation of
total GSH levels. Tissue was homogenized in 0.25 M sucrose
and centrifuged at 1000×g for 10 min to obtain the post-
nuclear supernatant. An aliquot of the post-nuclear super-
natant was used for estimation of γ-GCS activity. The
remaining portion of post-nuclear supernatant was centri-
fuged again at 14,000×g for 30 min to obtain the mitochondrial
pellet. The post-mitochondrial supernatant was used for
estimation of glutaredoxin activity. The mitochondrial pellet
was suspended in sucrose (0.25 M) and freeze–thawed prior to
assay of complex I activity. For the assay of GSH, the tissue
was frozen immediately in liquid nitrogen and homogenized
in 9 volumes of 100 mM potassium phosphate buffer (pH 7.4)
containing 1 mM EDTA. An aliquot of homogenate was added
to an equal volume of 5-sulfosalicylic acid (1%, w/v), mixed
and centrifuged at 10,000×g for 10 min, and the supernatant
was used for estimation of GSSG and total GSH. The protein
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described earlier (Balijepalli et al., 1999).
4.3. Estimation of glutathione (GSH+GSSG)
Total glutathione (GSH+GSSG) was estimated by the enzy-
matic recycling method (Sriram et al., 1998). The reaction
mixture consisted of 100 mM potassium phosphate buffer
(pH 7.4) containing 0.8 mM dithiobisnitrobenzoic acid and
0.5 U/ml glutathione reductase in a total volume of 0.44 ml.
The acid-soluble tissue supernatant (0.01 ml) prepared as
described above was added. The reaction was initiated by
adding 0.05 ml of 1.2 mM NADPH. The increase in absorbance
was measured at 412 nm over 3 min. A standard curve was
generated with known amount of GSSG. GSSG was estimated
using the acid-soluble supernatant described above. An
aliquot of the acid-soluble supernatant (0.1 ml) was also
transferred to a test tube containing solid sodium bicarbonate
(50mg). Immediately, 10 μl of iodoacetic acid (0.2M)was added
and the tubewas kept in dark at room temperature for 1 h. The
contents of the tube were centrifuged briefly, and an aliquot
was used for GSSG estimation (Sriram et al., 1997).
4.4. Assay of NADH: ubiquinone oxido-reductase
(complex I) activity
Complex I was assayed in mitochondrial preparations as
rotenone-sensitive NADH-ubiquinone oxido-reductase
(Kenchappa et al., 2002; Sriram et al., 1998). The assay was
performed in 35 mM potassium phosphate buffer (pH 7.4)
containing sodium cyanide (2.65 mM), magnesium chloride
(5 mM), EDTA (1 mM), bovine serum albumin (1 mg/ml) and
antimycin (2 μg/ml). Brain mitochondria (70–80 μg) and
ubiquinone 1 (0.05 mM) were added to the assay buffer to a
final volume of 0.48 ml. After preincubation of the reaction
mixture at room temperature for 2 min, the reaction was
initiated by addition 0.02 ml of 5 mMNADH solution. Test and
blank reactions were run separately. The rate of decrease of
absorbance at 340 nm was monitored over 3 min. The assay
was also carried out in the presence of rotenone to determine
rotenone-sensitive enzyme activity. Less than 2% of the total
activity was rotenone insensitive. The enzyme activity is
expressed as nanomoles of NADH oxidized/min/mg protein.
4.5. Assay of glutaredoxin activity
Glutaredoxin activity was estimated in post-mitochondrial
supernatant using cysteinyl-glutathione disulfide as substrate
as described elsewhere (Balijepalli et al., 1999). Post-mitochon-
drial supernatant from brain region or spinal cord was
suspended in 0.11 M potassium phosphate buffer (pH 7.4)
containing 0.5 mM GSH, 2.4 U/ml glutathione reductase and
3.5 mM NADPH. The reaction was initiated by addition of the
substrate, cysteinyl-glutathione disulfide (100 mM). The
decrease in absorbance of NADPH at 340 nm was measured
for 3min. Blanks were run simultaneously without addition of
post-mitochondrial supernatant. The net enzymatic rate was
obtained by subtraction of non-enzymatic rate from total rate.
The enzyme activity was expressed as nanomoles of NADPH
oxidized/min/mg protein.4.6. Assay of γ-glutamyl cysteine synthetase (γ-GCS)
activity
γ-GCS activity was measured in post-nuclear supernatant as
described by Chung et al. (1982) withminormodifications. The
reaction mixture consisted of ATP (50 mM), glutamate
(100 mM), bovine serum albumin (50 μg) and post-nuclear
supernatant (70–100 μg of protein). The volume was made up
to 125 μl with 100 mM Tris–HCl, (pH 8.2) and the reaction was
initiated by addition of the substrate, L-α-amino butyrate
(100 mM). The reaction mixture was incubated at 37 °C for
30 min. After incubation, reaction was stopped using 125 μl of
trichloroacetic acid (10%w/v). This was followed by addition of
1.0 ml of ammonium molybdate (1.6% w/v) and 0.4 ml of
ferrous sulfate (1% w/v) solution. Finally, the reaction mixture
was centrifuged at 5000×g for 5 min and the absorbance was
measured at 660 nm. Blank reactions without addition of
substrate were run simultaneously for each sample. A
standard curve was set up with known concentrations of
potassium dihydrogen phosphate (10–200 nmol). The amount
of phosphate (Pi) released by the enzyme was calculated from
the standard curve, and γ-GCS activity was expressed as μmol
of Pi released/h/mg protein.
4.7. Assay of glutathione reductase activity
The enzyme reduces glutathione disulfide to reduced glu-
tathione with concomitant oxidation of NADPH to NADP+. The
formation of NADP+ was measured by following a change in
absorbance at 340 nm. Reaction mixture contained GSSG
(1.6 mM) and protein (20–70 μg). The volume was made up to
1.0 ml by the addition of NADPH (0.05 ml), and decrease in
absorbance was monitored at 340 nm. Enzyme activity was
expressed as nmol of NADPH oxidized/min/mg protein (Horn,
1965).
4.8. Northern blotting
Total RNA from motor cortex and lumbosacral cord of vehicle
and L-BOAA treated male and female mice was extracted
using TRI reagent (Kenchappa et al., 2002). CNS regions from 3
animals were pooled for each sample preparation. Total RNA
was separated electrophoretically and transferred to posi-
tively charged nylon membranes by capillary transfer, UV
cross-linked and hybridized with digoxigenin-labeled cRNA,
prepared using the cDNA to γ-GCS (Kenchappa and
Ravindranath, 2003a). The blots were washed, incubated
with antibody to digoxigenin conjugated with alkaline phos-
phatase and bands were visualized by chromogenic substrate
for alkaline phosphatase. The relative intensity of the bands
was estimated using densitometry.
4.9. Immunohistochemistry
Paraffin embedded sections of mouse cortex and spinal cord
were taken and sections were dewaxed. The sections were
pressure cooked in sodium citrate buffer (0.01 M, pH 6) for
antigen retrieval, blocked with normal goat serum and
incubated with antibody of estrogen receptor α and β. Control
sectionswere incubatedwithnon-immuneserum.Thecortical
184 B R A I N R E S E A R C H 1 1 2 5 ( 2 0 0 6 ) 1 7 6 – 1 8 4sectionswerewashed, treatedwithbiotinylated anti-rabbit IgG
and incubated with streptavidin-fluorescein. The spinal cord
sections were washed and treated with anti rabbit Alexa-fluor
594. The sections were washed in phosphate buffer saline,
dried and mounted.
Statistical analysis was performed using Student's t test or
ANOVA followed by Student–Newman–Keul's or Dunnett's
test as appropriate.R E F E R E N C E S
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